Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom use as more than a “self-treatment”
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 6, pp. 684-694
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults
Kirsten E. Smith, Leigh V. Panlilio, Jeffrey D. Feldman, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2353401-e2353401
Open Access | Times Cited: 14
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study
Kirsten E. Smith, Jeffrey M. Rogers, Abhisheak Sharma, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 2, pp. 144-152
Closed Access | Times Cited: 12
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Prevalence of Kratom Use Disorder Among Kratom Consumers
Katherine Hill, Oliver Grundmann, Kirsten E. Smith, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 3, pp. 306-312
Closed Access | Times Cited: 9
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency
Jeffrey M. Rogers, Stephanie T. Weiss, David H. Epstein, et al.
Drug and Alcohol Dependence (2024) Vol. 260, pp. 111329-111329
Closed Access | Times Cited: 9
Examining the paradoxical effects of kratom: a narrative inquiry
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Kratom Alkaloids: A Blueprint?
Kirsten E. Smith, Abhisheak Sharma, Oliver Grundmann, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 2, pp. 195-197
Closed Access | Times Cited: 16
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Oliver Grundmann, Charles A. Veltri, Sara Morcos, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 5, pp. 963-977
Open Access | Times Cited: 14
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use
Katherine Hill, Jeffrey M. Rogers, Oliver Grundmann, et al.
The American Journal of Drug and Alcohol Abuse (2025), pp. 1-13
Open Access
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Novel methods for the remote investigation of emerging substances: Application to kratom.
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 32, Iss. 2, pp. 215-227
Open Access | Times Cited: 10
Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 282-292
Closed Access | Times Cited: 9
Pharmacokinetic Interaction of Kratom and Cannabidiol in Male Rats
Erin C. Berthold, Shyam H. Kamble, Raju S. Kanumuri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 318-318
Open Access | Times Cited: 3
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study
C. Austin Zamarripa, Tory R. Spindle, Leigh V. Panlilio, et al.
Traffic Injury Prevention (2024) Vol. 25, Iss. 4, pp. 594-603
Open Access | Times Cited: 3
Kratom withdrawal: Discussions and conclusions of a scientific expert forum
Jack E. Henningfield, Marek C. Chawarski, Albert Garcia‐Romeu, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100142-100142
Open Access | Times Cited: 6
Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 304-316
Closed Access | Times Cited: 6
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors
Katherine Hill, Stephen Gibson, Oliver Grundmann, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States
Matthew S. Ellis, Mance E. Buttram, Alyssa Forber, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 3, pp. 333-341
Closed Access | Times Cited: 6
Kratom availability in California vape shops
Molly A. Bowdring, Eric C. Leas, Monika Vishwakarma, et al.
Preventive Medicine Reports (2023) Vol. 35, pp. 102380-102380
Open Access | Times Cited: 5
Research and publication gaps on kratom and kratom products: a scoping review of current literature
Balasingam Vicknasingam, Thiruventhan Karunakaran, Marek C. Chawarski
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 282-291
Closed Access | Times Cited: 1
Use of Cannabinoids by People Who Consume Kratom in the United States
Katherine Hill, Oliver Grundmann, Leigh V. Panlilio, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 6, pp. 719-722
Closed Access | Times Cited: 1
Dynamic Topic Modeling of Kratom Use and Experiences: Insights on 13 years of Reddit Discussions
Seraphina Fong, Alessandro Carollo, Elisabeth Prevete, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top